Sartorius Stedim Biotech S.A. (LON: 0RG8)

Market Cap	16.94B
Revenue (ttm)	2.28B
Net Income (ttm)	133.64M
Shares Out	n/a
EPS (ttm)	1.40
PE Ratio	126.73
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 2, 2024

Volume	1,978
Average Volume	55,293
Open	200.00
Previous Close	196.98
Day's Range	200.30 - 205.30
52-Week Range	115.51 - 232.58
Beta	0.67
RSI	66.38
Earnings Date	Jan 27, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management servic...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 10,662
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RG8

Financial Performance

In 2023, Sartorius Stedim Biotech's revenue was 2.78 billion, a decrease of -20.53% compared to the previous year's 3.49 billion. Earnings were 309.70 million, a decrease of -64.65%.

Financial numbers in EUR